← Product Code [ILY](/submissions/PM/subpart-f%E2%80%94physical-medicine-therapeutic-devices/ILY) · K061080 # IR PRO 250 (K061080) _Lhasa Oms, Inc. · ILY · Jun 14, 2006 · Physical Medicine · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/PM/subpart-f%E2%80%94physical-medicine-therapeutic-devices/ILY/K061080 ## Device Facts - **Applicant:** Lhasa Oms, Inc. - **Product Code:** [ILY](/submissions/PM/subpart-f%E2%80%94physical-medicine-therapeutic-devices/ILY.md) - **Decision Date:** Jun 14, 2006 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 890.5500 - **Device Class:** Class 2 - **Review Panel:** Physical Medicine - **Attributes:** Therapeutic ## Indications for Use The IR Pro 250 is intended for use in the temporary relief of minor muscle and joint pain and stiffness, the temporary relief of minor joint pain associated with arthritis, the temporary increase in local circulation where applied, and relaxation of muscles. In addition, the lamp may help muscle spasms, minor sprains and strains, and minor back pain. ## Device Story IR Pro 250 is an infrared heating lamp for topical body application. Device emits infrared light (700–50,000 nm) via a 250-watt bulb powered by 120V AC. Mounted on a swivel stand with 5 casters; includes an automatic timer to control exposure duration. Used for temporary relief of minor muscle/joint pain, stiffness, arthritis, and muscle spasms; also promotes local circulation and muscle relaxation. Operated by user or clinician in a clinical or home setting. Output is thermal energy applied to the skin surface. Benefit is symptomatic relief of minor musculoskeletal conditions. If discomfort occurs, treatment must be discontinued to avoid potential burns. ## Clinical Evidence Bench testing only. Device safety was verified through testing in accordance with the Standard for Safety for Portable Sun/Heat Lamp, UL-482, 9th Edition (including sections UL 482/21, 22, 24, 26, 27, and 29). ## Technological Characteristics Infrared heating lamp; 250-watt infrared bulb; 120V AC 60 Hz power source; swivel stand with 5 casters; automatic timer. Tested to UL-482 safety standards. ## Regulatory Identification An infrared lamp is a device intended for medical purposes that emits energy at infrared frequencies (approximately 700 nanometers to 50,000 nanometers) to provide topical heating. ## Special Controls *Classification.* Class II (special controls). The device, when it is an infrared therapeutic heating lamp, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 890.9. ## Predicate Devices - TDP CQ-27 Lamp ([K003538](/device/K003538.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ K061080 # JUN 1 4 2006 ### F. 510(k) Summary Submitters information: Lhasa OMS, Inc. Establishment Registration: 230 Libbey Parkway 1222811 Weymouth, MA 02189 Contact Person: Mark W. Sheehan Telephone: 781-340-1072 ext. 20 Fax: 781-340-1637 Date Summary Prepared: April 14, 2006 Device name: Proprietary name: Common or usual name: Classification name: IR Pro 250 Infrared Heating Lamp Lamp, Infrared, Class II, 21 CFR 890.5500 Legally marketed device for substantial equivalence comparison: TDP CQ-27 Lamp, K003538 #### Description of the device: The IR Pro 250 lamp can be used for topical heating of the body. It is designed to emit light between 700 to 50,000 nanometers in wavelength. The lamp uses 120 volts AC power at 250 watts. It is mounted on a swivel stand with 5 casters. An automatic timer controls exposure time. #### Intended use of the device: The IR Pro 250 is intended for use in the temporary relief of minor muscle and joint pain and stiffness, the temporary relief of minor joint pain associated with arthritis, the temporary increase in local circulation where applied, and relaxation of muscles. In addition, the lamp may help muscle spasms, minor sprains and strains, and minor back pain. The intended use of the TDP CQ-27 Lamp is identical. Application should be pleasant and comfortable. If pain or discomfort is experienced treatment should be discontinued. Misuse may cause burns. #### Technological Characteristics: The IR Pro 250 and the TDP uses 120 volts, AC 60 Hz power. Each device emits infrared heat. The IR Pro 250 uses a 250 watt infrared bulb and the TDP lamp uses an emission plate to generate heat. Standards: A sample of the device was tested in accordance with the Standard for Safety for Portable Sun/Heat Lamp, UL-482, 9th Edition, September 2, 2005: UL 482/21, UL 482/22, UL 482/24, UL 482/26, UL 482/27, UL 482/29 F-1 {1}------------------------------------------------ Image /page/1/Picture/2 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo features a stylized eagle-like symbol with three curved lines representing wings or feathers. The symbol is enclosed within a circular border, and the text "DEPARTMENT OF HEALTH AND HUMAN SERVICES USA" is written around the border. JUN 1 4 2006 Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 Lhasa OMS, Inc. % Mr. Mark W. Sheehan Regulatory Affairs Officer 230 Libbey Parkway Weymouth, Massachusetts 021089 Re: K061080 Trade/Device Name: IR Pro 250 Regulation Number: 21 CFR 890.5500 Regulation Name: Infrared lamp Regulatory Class: II Product Code: ILY Dated: June 5, 2006 Received: June 6, 2006 Dear Mr. Sheehan: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA). it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition. FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA`s issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the stonic product radiation control provisions (Sections 531-542 of the Act): 21 CFR 100-01050. {2}------------------------------------------------ Page 2 - Mr. Mark W. Sheehan This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html. Sincerely vours. Яаибас Виесиит Mark N. Melkerson Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {3}------------------------------------------------ ## G. Indications for Use 510(k) Number (if known): Device Name: IR Pro 250 Intended use of the device: The IR Pro 250 is intended for use in the temporary relief of minor muscle and joint pain and stiffness, the temporary relief of minor joint pain associated with arthritis, the temporary increase in local circulation where applied, and relaxation of muscles. In addition, the lamp may help muscle spasms, minor sprains and strains, and minor back pain. AND/OR Prescription Use Over-The-Counter Use X (Part 21 CFR 810 Subpart D) (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Barbara Buchm Page 1 of 1 Division of General, Restorative, and Neurological Devices 510(k) Number. K061080 --- **Source:** [https://fda.innolitics.com/submissions/PM/subpart-f%E2%80%94physical-medicine-therapeutic-devices/ILY/K061080](https://fda.innolitics.com/submissions/PM/subpart-f%E2%80%94physical-medicine-therapeutic-devices/ILY/K061080) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com